Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
NCT03511118 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1600
Last updated 2026-04-24
Summary
Over half of women in the US who are breastfeeding their infants take prescription drugs. You are being asked to participate in this study because you are breastfeeding your infant and are currently taking, as part of your medical care, at least one of the drugs we are studying. We are interested in studying drugs commonly prescribed to women who are breastfeeding so we can learn more about the amount of drug that is transferred to breastmilk and estimate how much of drug that is consumed by breastfed infants.
Conditions
- Lactating Women on Select DOI
- Breastfed Infants of Mothers on Select DOI
Interventions
- DRUG
-
Fluvoxamine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Amoxicillin
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Duloxetine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Hydrocodone
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Paroxetine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Buprenorphine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Trazodone
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Valganciclovir
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Venlafaxine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Verapamil
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Remdesivir
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Anakinra
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Tranexamic acid (TXA)
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
labetalol
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
nifedipine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
clindamycin
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
oxycodone
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
escitalopram
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
sertraline
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
ondansetron
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Doxycycline
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Levofloxacin
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Methylphenidate
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Sumatriptan
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Citalopram
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Cyclobenzaprine
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Furosemide
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Gabapentin
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Hydrochlorothiazide
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Hydroxyurea
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Rosuvastatin
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
- DRUG
-
Topiramate
Understudied drugs will be administered in accordance with local SOC as prescribed by the lactating woman's healthcare provider.
Sponsors & Collaborators
-
The Emmes Company, LLC
collaborator INDUSTRY -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH - lead OTHER
Principal Investigators
-
Samia Aleem, MD · Duke University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-04
- Primary Completion
- 2027-07-23
- Completion
- 2028-07-31
- FDA Drug
- Yes
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women
NCT06021951 ·Status: COMPLETED ·Phase: PHASE4
-
Medications in Breast Milk: A Convenience Pharmacokinetic Study
NCT05099484 ·Status: COMPLETED
-
Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women
NCT07069582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk
NCT06042803 ·Status: RECRUITING
-
Study of Analgesics Drug and Human Milk Transfer in Mature Milk, to Avoid Breastfeeding Cessation Without Scientific Probes
NCT01854411 ·Status: COMPLETED
-
A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women
NCT06453356 ·Status: COMPLETED ·Phase: PHASE1
-
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
NCT02220348 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Breastfeeding on Lipid Profile and Cardiovascular Risk Markers in Women With Familial Hypercholesterolemia
NCT05367310 ·Status: ACTIVE_NOT_RECRUITING
-
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women
NCT04285684 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Lactation Study in Women Receiving Treatment With Ozanimod
NCT06181630 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of Amoxicillin Diffusion in Breast Milk According to a Population Pharmacokinetic Approach (CONCEPTION-AMOX)
NCT05051787 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women
NCT05441215 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Amoxicillin Dissolved in Human Milk
NCT01435824 ·Status: COMPLETED ·Phase: PHASE2
-
Antibody Detection of Vaccine-Induced Secretory Effects
NCT04895475 ·Status: COMPLETED
-
A Study of Breastfeeding in Buprenorphine Maintained Women
NCT01806389 ·Status: COMPLETED
-
RE104 Clinical Lactation Study
NCT06659263 ·Status: COMPLETED ·Phase: PHASE1
-
Progestin-Only Pill Use and Breastfeeding Study
NCT04965116 ·Status: COMPLETED ·Phase: PHASE4
-
Breastfeeding Advices on OTC Medicines With the Internet: What is the Best Medium
NCT06863597 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs
NCT05840809 ·Status: ACTIVE_NOT_RECRUITING
-
Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding
NCT01555931 ·Status: COMPLETED ·Phase: PHASE4
-
Postpartum Smoking Relapse Prevention by Breastfeeding Promotion
NCT04670822 ·Status: COMPLETED ·Phase: NA
-
Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
NCT01465022 ·Status: COMPLETED ·Phase: NA
-
Breastfeeding Failure: Influence of Smartphone Use and Distraction Factors
NCT05916079 ·Status: UNKNOWN
-
Excretion of Rivaroxaban in Human Breast Milk
NCT06831474 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women
NCT06644105 ·Status: COMPLETED ·Phase: NA